GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
84 hedge funds and large institutions have $488M invested in Global Blood Therapeutics, Inc. in 2016 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 38 increasing their positions, 19 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
11% less call options, than puts
Call options by funds: $5.29M | Put options by funds: $5.97M
38% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 24
Holders
84
Holding in Top 10
3
Calls
$5.29M
Puts
$5.97M
Top Buyers
| 1 | +$12.6M | |
| 2 | +$8.07M | |
| 3 | +$5.28M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.51M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$3.97M |
Top Sellers
| 1 | -$36M | |
| 2 | -$17.1M | |
| 3 | -$5.41M | |
| 4 |
CC
Casdin Capital
New York
|
-$4.38M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$4.21M |